Prevention of acute kidney injury.
Acute kidney injury is common and carries a high mortality. Many drugs have been evaluated for their role in preventing acute kidney injury, of which some are of no benefit and others may be harmful. This review discusses current interventions to prevent acute kidney injury and reviews the evidence base for each.
Brincat
Stephan
S
Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London SE1 9RT.
Hilton
Rachel
R
D000111:Acetylcysteine / Q000627:therapeutic use; D058186:Acute Kidney Injury / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D000493:Allopurinol / Q000627:therapeutic use; D000617:Aminoglycosides / Q000009:adverse effects; D000666:Amphotericin B / Q000009:adverse effects; D000935:Antifungal Agents / Q000009:adverse effects; D003287:Contrast Media / Q000009:adverse effects; D003681:Dehydration / Q000150:complications / Q000517:prevention & control; D018491:Dopamine Agonists / Q000627:therapeutic use; D005919:Glomerular Filtration Rate / Q000502:physiology*; D006801:Humans; D020896:Hypovolemia / Q000150:complications / Q000517:prevention & control; D045265:Natriuretic Peptides / Q000627:therapeutic use; D012076:Renal Agents / Q000627:therapeutic use; D012079:Renal Circulation / Q000502:physiology*; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000009:adverse effects; D013806:Theophylline / Q000627:therapeutic use
D000617:Aminoglycosides; D000935:Antifungal Agents; D003287:Contrast Media; D018491:Dopamine Agonists; D045265:Natriuretic Peptides; D012076:Renal Agents; D049994:Sodium Potassium Chloride Symporter Inhibitors; D000493:Allopurinol; D000666:Amphotericin B; D013806:Theophylline; D000111:Acetylcysteine